{"id":929191,"date":"2026-01-21T08:22:05","date_gmt":"2026-01-21T13:22:05","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/obagi-medical-unveils-aloha-program-to-launch-obagi-saypha-magiq-pioneering-the-largest-real-world-evaluation-of-a-new-hyaluronic-acid-filler\/"},"modified":"2026-01-21T08:22:05","modified_gmt":"2026-01-21T13:22:05","slug":"obagi-medical-unveils-aloha-program-to-launch-obagi-saypha-magiq-pioneering-the-largest-real-world-evaluation-of-a-new-hyaluronic-acid-filler","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/obagi-medical-unveils-aloha-program-to-launch-obagi-saypha-magiq-pioneering-the-largest-real-world-evaluation-of-a-new-hyaluronic-acid-filler\/","title":{"rendered":"Obagi Medical Unveils ALOHA Program to Launch Obagi\u00ae saypha\u00ae MagIQ\u2122 \u2013 Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler"},"content":{"rendered":"

\nProgram Designed to Drive Real World, Practice Focused Evidence with Injectables & Skincare
\n<\/h2>\n
\n

NEW YORK, Jan. 21, 2026 (GLOBE NEWSWIRE) — Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD) (\u201cWaldencast\u201d or the \u201cCompany\u201d), today announced the launch of the ALOHA (Aesthetic Leadership with Obagi Hyaluronic Acid) Program. This structured clinical collaboration initiative accelerates aesthetic innovation through practice-led insights and will support the introduction of Obagi\u00ae<\/sup> saypha\u00ae<\/sup> MagIQ\u2122 \u2013 the company’s first FDA-approved injectable hyaluronic acid (HA) filler with category-leading features including high useable HA content upon injection, consistent gel distribution, and a predictable injection force and swelling profile1<\/sup>.<\/p>\n

\u201cALOHA reflects our commitment to launching innovation differently and supporting category growth,\u201d said Drew Fine, U.S. General Manager, Professional Channel. \u201cBy gathering real-world data across diverse practice settings, we will demonstrate how Obagi\u00ae<\/sup> saypha\u00ae<\/sup> MagIQ\u2122 and Obagi skincare can drive practice success and patient satisfaction. The program’s inclusive design embodies our Aesthetics for All\u2122 ethos and invites broad industry participation.\u201d<\/p>\n

The ALOHA program creates a platform for practices to integrate real-world clinical experience into the product lifecycle. Participants will incorporate Obagi\u00ae<\/sup> saypha\u00ae<\/sup> MagIQ\u2122 into routine treatments and provide structured feedback via standardized surveys from injectors and practice owners. This authentic, practice-driven approach captures insights beyond pivotal trials, informing post-launch education, scientific content, and wider adoption. The program is expected to become the largest real-world evaluation of a newly launched HA injectable.<\/p>\n

\u201cWe are thrilled to partner with our valued Obagi providers to introduce this MagIQ-al new injectable,\u201d added Mr. Fine. \u201cPractices interested in participating are encouraged to sign up or contact their Obagi representative for more details.\u201d<\/p>\n

For more information about ALOHA, visit https:\/\/obagi-professional.com<\/a><\/p>\n

\n
\n About Obagi Medical<\/u>
\n <\/strong>
\n
Obagi Medical is an industry-leading, advanced skincare line rooted in research and skin biology, with a legacy of 35+ years of experience. Initially known for its leadership in the treatment of hyperpigmentation with the Obagi Nu-Derm\u00ae<\/sup> System, Obagi Medical products are designed to address a variety of skin concerns, including premature aging, photodamage, skin discoloration, acne, and sun damage. As the fastest-growing professional skincare brand in the U.S. in 2024,2\u00a0<\/sup>Obagi Medical empowers individuals to achieve healthy, beautiful skin. More information about Obagi Medical is available on the brand’s website, https:\/\/www.obagi.com<\/a>.<\/p>\n

\n
\n About Waldencast plc <\/u>
\n <\/strong>
\n
Founded by Michel Brousset and Hind Sebti, Waldencast\u2019s ambition is to build a global best-in-class beauty and wellness operating platform by developing, acquiring, accelerating, and scaling conscious, high-growth purpose-driven brands. Waldencast\u2019s vision is fundamentally underpinned by its brand-led business model that ensures proximity to its customers, business agility, and market responsiveness, while maintaining each brand\u2019s distinct DNA. The first step in realizing its vision was the Business Combination. As part of the Waldencast platform, its brands will benefit from the operational scale of a multi-brand platform; the expertise in managing global beauty brands at scale; a balanced portfolio to mitigate category fluctuations; asset light efficiency; and the market responsiveness and speed of entrepreneurial indie brands. For more information please visit: https:\/\/ir.waldencast.com<\/a>.<\/p>\n

\n
\n Media Contact:<\/u>
\n <\/strong>
\n
\n obagi@behrmancesa.com<\/a>\n <\/p>\n

\n Source:<\/strong> Waldencast plc<\/p>\n

    \n
  1. Puljic A, Frank K, Cohen J, Otto K, Mayr J, Hugh-Bloch A, Kuroki-Hasen\u00f6hrl, D. A Scientific Framework for Comparing Hyaluronic Acid Filler Crosslinking Technologies. Gels. 2025; 11(7):487<\/li>\n
  2. Among the Top 10 Professional Skin Care Brands in the U.S., According to Kline\u2019s 2024 Global Professional Skin Care Series (China, Europe and the U.S.).<\/li>\n<\/ol>\n

    \"\"
    \n
    \n \"\"\n <\/div>\n

    <\/div>\n","protected":false},"excerpt":{"rendered":"

    Program Designed to Drive Real World, Practice Focused Evidence with Injectables & Skincare NEW YORK, Jan. 21, 2026 (GLOBE NEWSWIRE) — Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD) (\u201cWaldencast\u201d or the \u201cCompany\u201d), today announced the launch of the ALOHA (Aesthetic Leadership with Obagi Hyaluronic Acid) Program. This structured clinical collaboration initiative accelerates aesthetic innovation through practice-led insights and will support the introduction of Obagi\u00ae saypha\u00ae MagIQ\u2122 \u2013 the company’s first FDA-approved injectable hyaluronic acid (HA) filler with category-leading features including high useable HA content upon injection, consistent gel distribution, and a predictable injection force and swelling profile1. \u201cALOHA reflects our commitment to launching innovation differently and supporting category growth,\u201d … <\/p>\n

    Continue reading “Obagi Medical Unveils ALOHA Program to Launch Obagi\u00ae saypha\u00ae MagIQ\u2122 \u2013 Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-929191","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nObagi Medical Unveils ALOHA Program to Launch Obagi\u00ae saypha\u00ae MagIQ\u2122 \u2013 Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/obagi-medical-unveils-aloha-program-to-launch-obagi-saypha-magiq-pioneering-the-largest-real-world-evaluation-of-a-new-hyaluronic-acid-filler\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Obagi Medical Unveils ALOHA Program to Launch Obagi\u00ae saypha\u00ae MagIQ\u2122 \u2013 Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Program Designed to Drive Real World, Practice Focused Evidence with Injectables & Skincare NEW YORK, Jan. 21, 2026 (GLOBE NEWSWIRE) — Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD) (\u201cWaldencast\u201d or the \u201cCompany\u201d), today announced the launch of the ALOHA (Aesthetic Leadership with Obagi Hyaluronic Acid) Program. This structured clinical collaboration initiative accelerates aesthetic innovation through practice-led insights and will support the introduction of Obagi\u00ae saypha\u00ae MagIQ\u2122 \u2013 the company’s first FDA-approved injectable hyaluronic acid (HA) filler with category-leading features including high useable HA content upon injection, consistent gel distribution, and a predictable injection force and swelling profile1. \u201cALOHA reflects our commitment to launching innovation differently and supporting category growth,\u201d … Continue reading "Obagi Medical Unveils ALOHA Program to Launch Obagi\u00ae saypha\u00ae MagIQ\u2122 \u2013 Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/obagi-medical-unveils-aloha-program-to-launch-obagi-saypha-magiq-pioneering-the-largest-real-world-evaluation-of-a-new-hyaluronic-acid-filler\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-21T13:22:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyOTMxMyM3MzcxNTk1IzIyMjUzNDY=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/obagi-medical-unveils-aloha-program-to-launch-obagi-saypha-magiq-pioneering-the-largest-real-world-evaluation-of-a-new-hyaluronic-acid-filler\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/obagi-medical-unveils-aloha-program-to-launch-obagi-saypha-magiq-pioneering-the-largest-real-world-evaluation-of-a-new-hyaluronic-acid-filler\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Obagi Medical Unveils ALOHA Program to Launch Obagi\u00ae saypha\u00ae MagIQ\u2122 \u2013 Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler\",\"datePublished\":\"2026-01-21T13:22:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/obagi-medical-unveils-aloha-program-to-launch-obagi-saypha-magiq-pioneering-the-largest-real-world-evaluation-of-a-new-hyaluronic-acid-filler\\\/\"},\"wordCount\":589,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/obagi-medical-unveils-aloha-program-to-launch-obagi-saypha-magiq-pioneering-the-largest-real-world-evaluation-of-a-new-hyaluronic-acid-filler\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyOTMxMyM3MzcxNTk1IzIyMjUzNDY=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/obagi-medical-unveils-aloha-program-to-launch-obagi-saypha-magiq-pioneering-the-largest-real-world-evaluation-of-a-new-hyaluronic-acid-filler\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/obagi-medical-unveils-aloha-program-to-launch-obagi-saypha-magiq-pioneering-the-largest-real-world-evaluation-of-a-new-hyaluronic-acid-filler\\\/\",\"name\":\"Obagi Medical Unveils ALOHA Program to Launch Obagi\u00ae saypha\u00ae MagIQ\u2122 \u2013 Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/obagi-medical-unveils-aloha-program-to-launch-obagi-saypha-magiq-pioneering-the-largest-real-world-evaluation-of-a-new-hyaluronic-acid-filler\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/obagi-medical-unveils-aloha-program-to-launch-obagi-saypha-magiq-pioneering-the-largest-real-world-evaluation-of-a-new-hyaluronic-acid-filler\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyOTMxMyM3MzcxNTk1IzIyMjUzNDY=\",\"datePublished\":\"2026-01-21T13:22:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/obagi-medical-unveils-aloha-program-to-launch-obagi-saypha-magiq-pioneering-the-largest-real-world-evaluation-of-a-new-hyaluronic-acid-filler\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/obagi-medical-unveils-aloha-program-to-launch-obagi-saypha-magiq-pioneering-the-largest-real-world-evaluation-of-a-new-hyaluronic-acid-filler\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/obagi-medical-unveils-aloha-program-to-launch-obagi-saypha-magiq-pioneering-the-largest-real-world-evaluation-of-a-new-hyaluronic-acid-filler\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyOTMxMyM3MzcxNTk1IzIyMjUzNDY=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyOTMxMyM3MzcxNTk1IzIyMjUzNDY=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/obagi-medical-unveils-aloha-program-to-launch-obagi-saypha-magiq-pioneering-the-largest-real-world-evaluation-of-a-new-hyaluronic-acid-filler\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Obagi Medical Unveils ALOHA Program to Launch Obagi\u00ae saypha\u00ae MagIQ\u2122 \u2013 Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Obagi Medical Unveils ALOHA Program to Launch Obagi\u00ae saypha\u00ae MagIQ\u2122 \u2013 Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/obagi-medical-unveils-aloha-program-to-launch-obagi-saypha-magiq-pioneering-the-largest-real-world-evaluation-of-a-new-hyaluronic-acid-filler\/","og_locale":"en_US","og_type":"article","og_title":"Obagi Medical Unveils ALOHA Program to Launch Obagi\u00ae saypha\u00ae MagIQ\u2122 \u2013 Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler - Market Newsdesk","og_description":"Program Designed to Drive Real World, Practice Focused Evidence with Injectables & Skincare NEW YORK, Jan. 21, 2026 (GLOBE NEWSWIRE) — Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD) (\u201cWaldencast\u201d or the \u201cCompany\u201d), today announced the launch of the ALOHA (Aesthetic Leadership with Obagi Hyaluronic Acid) Program. This structured clinical collaboration initiative accelerates aesthetic innovation through practice-led insights and will support the introduction of Obagi\u00ae saypha\u00ae MagIQ\u2122 \u2013 the company’s first FDA-approved injectable hyaluronic acid (HA) filler with category-leading features including high useable HA content upon injection, consistent gel distribution, and a predictable injection force and swelling profile1. \u201cALOHA reflects our commitment to launching innovation differently and supporting category growth,\u201d … Continue reading \"Obagi Medical Unveils ALOHA Program to Launch Obagi\u00ae saypha\u00ae MagIQ\u2122 \u2013 Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/obagi-medical-unveils-aloha-program-to-launch-obagi-saypha-magiq-pioneering-the-largest-real-world-evaluation-of-a-new-hyaluronic-acid-filler\/","og_site_name":"Market Newsdesk","article_published_time":"2026-01-21T13:22:05+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyOTMxMyM3MzcxNTk1IzIyMjUzNDY=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/obagi-medical-unveils-aloha-program-to-launch-obagi-saypha-magiq-pioneering-the-largest-real-world-evaluation-of-a-new-hyaluronic-acid-filler\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/obagi-medical-unveils-aloha-program-to-launch-obagi-saypha-magiq-pioneering-the-largest-real-world-evaluation-of-a-new-hyaluronic-acid-filler\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Obagi Medical Unveils ALOHA Program to Launch Obagi\u00ae saypha\u00ae MagIQ\u2122 \u2013 Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler","datePublished":"2026-01-21T13:22:05+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/obagi-medical-unveils-aloha-program-to-launch-obagi-saypha-magiq-pioneering-the-largest-real-world-evaluation-of-a-new-hyaluronic-acid-filler\/"},"wordCount":589,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/obagi-medical-unveils-aloha-program-to-launch-obagi-saypha-magiq-pioneering-the-largest-real-world-evaluation-of-a-new-hyaluronic-acid-filler\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyOTMxMyM3MzcxNTk1IzIyMjUzNDY=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/obagi-medical-unveils-aloha-program-to-launch-obagi-saypha-magiq-pioneering-the-largest-real-world-evaluation-of-a-new-hyaluronic-acid-filler\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/obagi-medical-unveils-aloha-program-to-launch-obagi-saypha-magiq-pioneering-the-largest-real-world-evaluation-of-a-new-hyaluronic-acid-filler\/","name":"Obagi Medical Unveils ALOHA Program to Launch Obagi\u00ae saypha\u00ae MagIQ\u2122 \u2013 Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/obagi-medical-unveils-aloha-program-to-launch-obagi-saypha-magiq-pioneering-the-largest-real-world-evaluation-of-a-new-hyaluronic-acid-filler\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/obagi-medical-unveils-aloha-program-to-launch-obagi-saypha-magiq-pioneering-the-largest-real-world-evaluation-of-a-new-hyaluronic-acid-filler\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyOTMxMyM3MzcxNTk1IzIyMjUzNDY=","datePublished":"2026-01-21T13:22:05+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/obagi-medical-unveils-aloha-program-to-launch-obagi-saypha-magiq-pioneering-the-largest-real-world-evaluation-of-a-new-hyaluronic-acid-filler\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/obagi-medical-unveils-aloha-program-to-launch-obagi-saypha-magiq-pioneering-the-largest-real-world-evaluation-of-a-new-hyaluronic-acid-filler\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/obagi-medical-unveils-aloha-program-to-launch-obagi-saypha-magiq-pioneering-the-largest-real-world-evaluation-of-a-new-hyaluronic-acid-filler\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyOTMxMyM3MzcxNTk1IzIyMjUzNDY=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyOTMxMyM3MzcxNTk1IzIyMjUzNDY="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/obagi-medical-unveils-aloha-program-to-launch-obagi-saypha-magiq-pioneering-the-largest-real-world-evaluation-of-a-new-hyaluronic-acid-filler\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Obagi Medical Unveils ALOHA Program to Launch Obagi\u00ae saypha\u00ae MagIQ\u2122 \u2013 Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/929191","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=929191"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/929191\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=929191"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=929191"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=929191"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}